Ningbo Sanxing Medical Electric Co.,Ltd. (SHA: 601567)

Ningbo Sanxing Medical Electric Co.,Ltd. Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	13,357	11,261	8,939	6,911	6,995	6,730
Other Revenue	201.71	201.71	158.82	112.31	97.95	74.84
Revenue	13,558	11,463	9,098	7,023	7,093	6,805
Revenue Growth (YoY)	28.71%	25.99%	29.55%	-0.98%	4.22%	15.92%
Cost of Revenue	8,712	7,592	6,487	5,259	5,066	4,851
Gross Profit	4,846	3,871	2,611	1,764	2,027	1,955
Selling, General & Admin	1,974	1,635	1,188	845.78	771.53	855.95
Research & Development	557.32	463.77	320.81	285.94	298.71	302.75
Other Operating Expenses	28.29	83.51	23.36	40.92	25.63	20.77
Operating Expenses	2,567	2,207	1,522	1,215	1,070	1,238
Operating Income	2,279	1,664	1,089	548.89	956.47	717.05
Interest Expense	-101.67	-52.75	-61.33	-83.25	-28.45	-31.7
Interest & Investment Income	362.22	342.58	123.66	239.61	360.29	588.78
Currency Exchange Gain (Loss)	40.92	40.92	55	-32.97	-79.98	-3.38
Other Non Operating Income (Expenses)	-84.3	-15.24	-17.45	42.5	-111.27	7.02
EBT Excluding Unusual Items	2,496	1,980	1,189	714.77	1,097	1,278
Impairment of Goodwill	-8.68	-8.68	-9.49	-1.79	-15.48	-7.8
Gain (Loss) on Sale of Investments	-48.65	116.97	-107.48	103.7	65.38	-102.61
Gain (Loss) on Sale of Assets	-1.61	-1.09	-1.88	-7.65	-0.2	3.74
Asset Writedown	-34.32	-0.68	1.57	-4.59	-4.78	-6.31
Other Unusual Items	216.96	175.87	80.78	42.38	46.55	35.15
Pretax Income	2,620	2,262	1,152	846.81	1,189	1,200
Income Tax Expense	375.4	341.26	187.04	139.2	227.65	184.79
Earnings From Continuing Operations	2,245	1,921	965.01	707.61	960.88	1,015
Minority Interest in Earnings	-14.57	-17.1	-16.89	-17.57	-4.76	-10.77
Net Income	2,230	1,904	948.12	690.04	956.12	1,004
Net Income to Common	2,230	1,904	948.12	690.04	956.12	1,004
Net Income Growth	28.47%	100.79%	37.40%	-27.83%	-4.80%	97.68%
Shares Outstanding (Basic)	1,402	1,410	1,415	1,380	1,386	1,395
Shares Outstanding (Diluted)	1,402	1,410	1,415	1,380	1,386	1,395
Shares Change (YoY)	-1.72%	-0.35%	2.54%	-0.40%	-0.67%	-1.16%
EPS (Basic)	1.59	1.35	0.67	0.50	0.69	0.72
EPS (Diluted)	1.59	1.35	0.67	0.50	0.69	0.72
EPS Growth	30.72%	101.49%	34.00%	-27.54%	-4.17%	100.00%
Free Cash Flow	1,727	1,345	818.7	-96.3	1,024	694
Free Cash Flow Per Share	1.23	0.95	0.58	-0.07	0.74	0.50
Dividend Per Share	0.650	0.650	0.350	0.320	0.350	0.210
Dividend Growth	85.71%	85.71%	9.38%	-8.57%	66.67%	-30.00%
Gross Margin	35.74%	33.77%	28.70%	25.11%	28.57%	28.72%
Operating Margin	16.81%	14.52%	11.97%	7.82%	13.49%	10.54%
Profit Margin	16.45%	16.61%	10.42%	9.83%	13.48%	14.76%
Free Cash Flow Margin	12.74%	11.74%	9.00%	-1.37%	14.44%	10.20%
EBITDA	2,534	1,908	1,317	744.1	1,144	890.26
EBITDA Margin	18.69%	16.64%	14.48%	10.60%	16.12%	13.08%
D&A For EBITDA	254.95	243.7	228.7	195.22	187.11	173.21
EBIT	2,279	1,664	1,089	548.89	956.47	717.05
EBIT Margin	16.81%	14.52%	11.97%	7.82%	13.49%	10.54%
Effective Tax Rate	14.33%	15.09%	16.24%	16.44%	19.15%	15.40%
Revenue as Reported	13,558	11,463	9,098	7,023	7,093	6,805
Advertising Expenses	-	18.07	11.28	8.04	7.54	21.83

Source: S&P Capital IQ. Standard template. Financial Sources.